Pharmaceutical Technology4d
Tevimbra by BeiGene for Metastatic Colorectal Cancer: Likelihood of Approval
Tevimbra is under clinical development by BeiGene and currently in Phase II for Metastatic Colorectal Cancer. According to GlobalData, Phase II drugs for Metastatic Colorectal Cancer have a 34% phase ...
Pharmaceutical Technology4d
Vactosertib by MedPacto for Metastatic Colorectal Cancer: Likelihood of Approval
Vactosertib is under clinical development by MedPacto and currently in Phase I for Metastatic Colorectal Cancer.
Cure Today7d
Subcutaneous Opdivo Receives FDA Approval for Advanced, Metastatic Solid Tumors
Opdivo Qvantig is approved for solid tumors, including melanoma, renal cell carcinoma, and non-small cell lung cancer. The ...
The American Journal of Managed Care1d
FDA Approves First Subcutaneous Nivolumab Injection in Most Solid Tumors
FDA approves the first subcutaneous version of nivolumab, making PD-1 inhibitors available to new groups of patients.
Armed robbery in Revesby13d
FDA Greenlights Pfizer Combo for Metastatic Colorectal Cancer
Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved BRAFTOVI® (encorafenib) in combination with ...
Targeted Oncology7d
FDA Approves Subcutaneous Nivolumab Across Existing Solid Tumor Indications
On December 27, 2024, subcutaneous nivolumab (Opdivo Qvantig) was approved by the FDA in all previously approved adult solid ...